Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2002; 40:367-374
© 2002 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ranki, H. J.
Right arrow Articles by Jovanovic, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ranki, H. J.
Right arrow Articles by Jovanovic, A.

17ß-Estradiol regulates expression of KATP channels in heart-derived H9c2 cells

Harri J. Ranki, PhD*, Grant R. Budas, BSc*, Russell M. Crawford, PhD*, Anthony M. Davies, BSc* and Aleksandar Jovanovic, MD, PhD*,*

* Tayside Institute of Child Health, Ninewells Hospital & Medical School, University of Dundee, Dundee, Scotland, United Kingdom



View larger version (46K):

[in a new window]
 
Figure 1 Kir6.2 and sulfonylurea receptor 2A (SUR2A) messenger ribonucleic acid levels in untreated and 17ß-estradiol (E2)-treated H9c2 heart cells. (A to D) Reverse transcription-polymerase chain reaction (RT-PCR) products obtained with Kir6.2-, SUR2A- and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-specific primers from untreated and E2-treated cells. (A1 to C1) Graphs corresponding to RT-PCR products depicted in A to D. Each bar represents mean ± SEM. *p < 0.05 when compared with the control.

 


View larger version (34K):

[in a new window]
 
Figure 2 Adenosine triphosphate-sensitive potassium channel levels in plasma membrane of untreated and 17-ßestradiol (E2)-treated H9c2 cells. Western blot with anti-Kir6.2 (A) and anti-sulfonylurea receptor 2A (SUR2A) (B) of anti-SUR2A (A) and anti-Kir6.2 (B) immunoprecipitate pellets from membrane fractions from untreated and E2-treated H9c2 cells. (A1 and B1) Graphs correspond to A and B. Each bar represents mean ± SEM. *p < 0.05.IP = immunoprecipitate.

 


View larger version (60K):

[in a new window]
 
Figure 3 Hypoxia/reoxygenation (H/R)-induced Ca2+ loading in untreated and 17-ßestradiol (E2)-treated H9c2 cells in the absence and presence of HMR 1098 (3 µM) and 5-hydroxydecanoate (5-HD) (50 µM), sarcolemmal and mitochondrial Adenosine triphosphate-sensitive potassium channel blockers, respectively. (A) Epifluorescent digital images of untreated and E2-treated Fura-2 loaded cells before (left panel) and after H/R (right panel). White bar corresponds to 30 µm. Graphs are time courses of intracellular concentration of Ca2+ and correspond to experiments depicted on the left. Each line on graphs represents a single cell from the corresponding image field. (B) Percentage of cells that responded (defined as 50% increase in resting Ca2+ with the time-course pattern of Ca2+ increase as depicted in A)/did not respond to H/R with Ca2+ loading under control conditions (untreated) and 24 h treatment with E2 in the absence (E2) and presence of HMR 1098 (E2 + HMR 1098) and 5-HD (E2 + 5-HD), n = 29 to 45.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement